Who It's For

The Calmare® platform is highly effective in the treatment of pain and has long-lasting effects, an important benefit for both physicians and their patients. Clinical studies have shown that the technology successfully reduces pain in more than 80 percent of treated patients without the adverse side effects commonly associated with drugs, therefore providing patients with a markedly improved quality of life.

Get Adobe Flash player

  • Chemotherapy-induced Peripheral Neuropathy (CIPN)
  • Chronic Cancer Pain
  • Failed Back Surgery Syndrome (FBSS)
  • Sciatic and Lumbar Pain
  • Phantom Limb Syndrome
  • Postherpetic Neuralgia (PHN)
  • Post-surgical Neuropathic Pain
  • Brachial Plexus Neuropathy
  • Low Back Pain (LBP)
  • Chronic Neuropathic Pain

Due to the manner in which Calmare Pain Therapy Treatment operates, the following should be considered for possible exclusion:

  • pacemaker or automatic defibrillator
  • aneurysm clip, vena cava clips, or skull plates (metal implants for orthopedic repair, e.g. pins, plates, joint replacements are allowed)
  • pregnant and/or breastfeeding
  • history of epilepsy, brain damage, use of anti-convulsants other than pain control
  • prior celiac plexus block, or other neurolytic pain control treatment, within 4 weeks
  • wounds or skin irritation in areas where the electrodes are required to be placed
  • history of, or have been treated for myocardial infarction or ischemic heart disease with the past six months
  • severe arrhythmia or any form of equivalent heart disease
  • implanted drug delivery system
  • active withdrawal from drugs and/or alcohol
  • previous intolerance to transcutaneous electronic nerve stimulation
  • latex allergies
  • you have pain originating in the central nervous system
  • stimulation over the neck (laryngeal and pharyngeal) due to muscle contractions may be strong enough to close the airway or cause difficulty in breathing
  • because this device is capable of delivering a charge per pulse of 25 micro coulombs or greater, you should not place electrodes in a trans-thoracic position (may cause cardiac arrhythmia)
  • you are prone to skin irritation (isolated cases have occurred)
  • you have not had a clear diagnosis of neuropathic pain
  • you have a implanted pain stimulator (operating or nonoperational) in which the proposed treatment is in the area of the implanted device (electrical current to area may interfere with the operation of the implanted device)
  • you are connected to other electronic monitoring equipment (ECG monitor) - may not operate properly with the medical device is in use
  • you are on neuroleptic medications (examples: carbamazepine, pregabalin, gabapentin) which appear to "interfere with treatment efficacy" and "decrease longevity" of no-pain post treatment protocol